These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19779315)

  • 21. Ovarian cancer screening.
    Sparks JM; Varner RE
    Obstet Gynecol; 1991 May; 77(5):787-92. PubMed ID: 2014097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mass-screening for ovarian cancer].
    Sato S; Higuchi T; Yokoyama Y; Sakamoto T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():601-4. PubMed ID: 15535316
    [No Abstract]   [Full Text] [Related]  

  • 23. Pure primary non-gestational ovarian choriocarcinoma: a diagnostic dilemma.
    Gon S; Majumdar B; Barui G; Karmakar R; Bhattacharya A
    Indian J Pathol Microbiol; 2010; 53(1):178-80. PubMed ID: 20090265
    [No Abstract]   [Full Text] [Related]  

  • 24. Transvaginal sonographic measurements of postmenopausal ovarian volume as a possible detection of ovarian neoplasia.
    Zalel Y; Tepper R; Altaras M; Beyth Y
    Acta Obstet Gynecol Scand; 1996 Aug; 75(7):668-71. PubMed ID: 8822663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian cancer screening: are there any options?
    Tiffen J; Mahon SM
    Clin J Oncol Nurs; 2005 Jun; 9(3):369-72. PubMed ID: 15973849
    [No Abstract]   [Full Text] [Related]  

  • 26. Ovarian cancer early detection program.
    Farley KM
    Oncol Nurs Forum; 1999 Jun; 26(5):833-4. PubMed ID: 10382179
    [No Abstract]   [Full Text] [Related]  

  • 27. Advances in the early detection of ovarian carcinoma.
    Garner EI
    J Reprod Med; 2005 Jun; 50(6):447-53. PubMed ID: 16050569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How appropriate are the american college of radiology appropriateness criteria for ovarian cancer screening.
    Dubinsky TJ
    Ultrasound Q; 2010 Dec; 26(4):225-6. PubMed ID: 21084937
    [No Abstract]   [Full Text] [Related]  

  • 29. Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study.
    Schutter EM; Sohn C; Kristen P; Möbus V; Crombach G; Kaufmann M; Caffier H; Kreienberg R; Verstraeten AA; Kenemans P
    Gynecol Oncol; 1998 Apr; 69(1):56-63. PubMed ID: 9570999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A modified transvaginal sonographic technique for better ovarian evaluation.
    Pardo J; Kaplan B; Rosenberg C; Ovadia Y; Neri A
    J Clin Ultrasound; 1993 Oct; 21(8):503-5. PubMed ID: 8270667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.
    Robertson DM; Stephenson T; Pruysers E; McCloud P; Tsigos A; Groome N; Mamers P; Burger HG
    J Clin Endocrinol Metab; 2002 Feb; 87(2):816-24. PubMed ID: 11836327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian cancer screening. American College of Radiology. ACR Appropriateness Criteria.
    Böhm-Vélez M; Mendelson E; Bree R; Finberg H; Fishman EK; Hricak H; Laing F; Sartoris D; Thurmond A; Goldstein S
    Radiology; 2000 Jun; 215 Suppl():861-71. PubMed ID: 11037511
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.
    Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA
    Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Origin of ovarian cancer may have implications for screening.
    Tuma RS
    J Natl Cancer Inst; 2010 Jan; 102(1):11-3. PubMed ID: 20023201
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibins and ovarian cancer.
    Robertson DM; Pruysers E; Burger HG; Jobling T; McNeilage J; Healy D
    Mol Cell Endocrinol; 2004 Oct; 225(1-2):65-71. PubMed ID: 15451569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why don't doctors screen for ovarian cancer with annual pelvic ultrasounds like they do mammograms for breast cancer? Is it just a matter of money?
    Robb-Nicholson C
    Harv Womens Health Watch; 1999 Apr; 6(8):8. PubMed ID: 10095276
    [No Abstract]   [Full Text] [Related]  

  • 37. Is there a place for screening in ovarian cancer?
    MacDonald ND; Jacobs IJ
    Eur J Obstet Gynecol Reprod Biol; 1999 Feb; 82(2):155-7. PubMed ID: 10206408
    [No Abstract]   [Full Text] [Related]  

  • 38. Postmenopausal uterine leiomyoma with hemorrhagic cystic degeneration mimicking ovarian malignancy.
    Jao MS; Huang KG; Jung SM; Hwang LL
    Taiwan J Obstet Gynecol; 2007 Dec; 46(4):431-4. PubMed ID: 18182354
    [No Abstract]   [Full Text] [Related]  

  • 39. [Problems and contradictions in the screening of ovarian cancer].
    Bucchi L
    Epidemiol Prev; 1995 Dec; 19(65):304-9. PubMed ID: 8852079
    [No Abstract]   [Full Text] [Related]  

  • 40. Ovarian cancer. Clinical and genetic considerations.
    Ahonen KA
    Adv Nurse Pract; 2009 Jan; 17(1):47-9. PubMed ID: 19999478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.